EU approves AZ’ Bydureon BCise device

30th August 2018 Uncategorised 0

AstraZeneca says the European Commission has approved a new formulation of its once-weekly diabetes drug Bydureon.

More: EU approves AZ’ Bydureon BCise device
Source: News